NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 313 filers reported holding NOVOCURE LTD in Q4 2022. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $37,000 | +8.8% | 500 | 0.0% | 0.01% | +9.1% |
| Q2 2022 | $34,000 | -17.1% | 500 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $41,000 | +10.8% | 500 | 0.0% | 0.01% | +10.0% |
| Q4 2021 | $37,000 | -36.2% | 500 | 0.0% | 0.01% | -41.2% |
| Q3 2021 | $58,000 | -47.3% | 500 | 0.0% | 0.02% | -48.5% |
| Q2 2021 | $110,000 | +66.7% | 500 | 0.0% | 0.03% | +57.1% |
| Q1 2021 | $66,000 | -23.3% | 500 | 0.0% | 0.02% | -25.0% |
| Q4 2020 | $86,000 | +56.4% | 500 | 0.0% | 0.03% | +40.0% |
| Q3 2020 | $55,000 | +139.1% | 500 | +25.0% | 0.02% | +150.0% |
| Q2 2020 | $23,000 | -11.5% | 400 | 0.0% | 0.01% | -20.0% |
| Q1 2020 | $26,000 | – | 400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |